Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2024 Earnings Call Transcript March 10, 2025
Lineage Cell Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.04.
Operator: Thank you for standing by. My name is Rochelle and I will be your conference operator today. At this time, I would like to welcome everyone to the Lineage Cell Therapeutics Fourth Quarter and Full Year 2024 Conference Call. At this time, all participants are in a listen only mode....
